Clinical trial
Artemisinin-resistant Plasmodium Falciparum Malaria in Cambodia
NCT01736319 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Artemisinin-resistant Plasmodium Falciparum Malaria in Cambodia
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 26, 2012
- Completion date
- April 6, 2016
- Enrollment
- 561 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
plasmodium falciparum malaria